AVA-Trap / Avalon GloboCare - LARVOL DELTA

Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19 (GlobeNewswire) - "Avalon GloboCare Corp....today announced an update on its four scientific research and clinical development programs in cell therapy and COVID-19 related initiatives, including...AVA-Trap™ for mitigating COVID-19 'cytokine storm,' and S-layer based COVID-19 vaccine....Avalon’s AVA-Trap™ therapeutic program is currently entering animal model testing followed by expedited clinical studies....Avalon plans to complete the proof-of-concept pre-clinical studies in 2020, followed by first-in-human clinical study of this candidate vaccine during 2021."

Cytokine storm • New trial • Preclinical • Infectious Disease • Novel Coronavirus Disease